486 related articles for article (PubMed ID: 23260142)
1. Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection.
Pos W; Sethi DK; Call MJ; Schulze MS; Anders AK; Pyrdol J; Wucherpfennig KW
Cell; 2012 Dec; 151(7):1557-68. PubMed ID: 23260142
[TBL] [Abstract][Full Text] [Related]
2. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
Schulze MS; Anders AK; Sethi DK; Call MJ
PLoS One; 2013; 8(7):e69228. PubMed ID: 23976922
[TBL] [Abstract][Full Text] [Related]
3. Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis.
Stratikos E; Mosyak L; Zaller DM; Wiley DC
J Exp Med; 2002 Jul; 196(2):173-83. PubMed ID: 12119342
[TBL] [Abstract][Full Text] [Related]
4. HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation.
Poluektov YO; Kim A; Hartman IZ; Sadegh-Nasseri S
PLoS One; 2013; 8(8):e71228. PubMed ID: 23951115
[TBL] [Abstract][Full Text] [Related]
5. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding.
Murthy VL; Stern LJ
Structure; 1997 Oct; 5(10):1385-96. PubMed ID: 9351812
[TBL] [Abstract][Full Text] [Related]
6. HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide.
Anders AK; Call MJ; Schulze MS; Fowler KD; Schubert DA; Seth NP; Sundberg EJ; Wucherpfennig KW
Nat Immunol; 2011 Jan; 12(1):54-61. PubMed ID: 21131964
[TBL] [Abstract][Full Text] [Related]
7. Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4-HLA-DR1 complex.
Wang XX; Li Y; Yin Y; Mo M; Wang Q; Gao W; Wang L; Mariuzza RA
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15960-5. PubMed ID: 21900604
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: TCR contacts as anchors: effects on affinity and HLA-DM stability.
Anderson MW; Gorski J
J Immunol; 2003 Dec; 171(11):5683-7. PubMed ID: 14634075
[TBL] [Abstract][Full Text] [Related]
9. Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange.
Painter CA; Negroni MP; Kellersberger KA; Zavala-Ruiz Z; Evans JE; Stern LJ
Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19329-34. PubMed ID: 22084083
[TBL] [Abstract][Full Text] [Related]
10. The Thermodynamic Mechanism of Peptide-MHC Class II Complex Formation Is a Determinant of Susceptibility to HLA-DM.
Ferrante A; Templeton M; Hoffman M; Castellini MJ
J Immunol; 2015 Aug; 195(3):1251-61. PubMed ID: 26116504
[TBL] [Abstract][Full Text] [Related]
11. The N-terminal region of photocleavable peptides that bind HLA-DR1 determines the kinetics of fragment release.
Negroni MP; Stern LJ
PLoS One; 2018; 13(7):e0199704. PubMed ID: 29965980
[TBL] [Abstract][Full Text] [Related]
12. Short peptide sequences mimic HLA-DM functions.
Chou CL; Mirshahidi S; Su KW; Kim A; Narayan K; Khoruzhenko S; Xu M; Sadegh-Nasseri S
Mol Immunol; 2008 Apr; 45(7):1935-43. PubMed ID: 18054387
[TBL] [Abstract][Full Text] [Related]
13. Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1.
Natarajan SK; Stern LJ; Sadegh-Nasseri S
J Immunol; 1999 Mar; 162(6):3463-70. PubMed ID: 10092802
[TBL] [Abstract][Full Text] [Related]
14. Formation of two peptide/MHC II isomers is catalyzed differentially by HLA-DM.
Belmares MP; Busch R; Mellins ED; McConnell HM
Biochemistry; 2003 Jan; 42(3):838-47. PubMed ID: 12534297
[TBL] [Abstract][Full Text] [Related]
15. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
16. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.
Ghosh P; Amaya M; Mellins E; Wiley DC
Nature; 1995 Nov; 378(6556):457-62. PubMed ID: 7477400
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism at beta 85 and not beta 86 of HLA-DR1 is predominantly responsible for restricting the nature of the anchor side chain: implication for concerted effects of class II MHC polymorphism.
Wu S; Gorski J
Int Immunol; 1997 Oct; 9(10):1495-502. PubMed ID: 9352354
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
Rosloniec EF; Whittington KB; Zaller DM; Kang AH
J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1.
Zavala-Ruiz Z; Sundberg EJ; Stone JD; DeOliveira DB; Chan IC; Svendsen J; Mariuzza RA; Stern LJ
J Biol Chem; 2003 Nov; 278(45):44904-12. PubMed ID: 12952957
[TBL] [Abstract][Full Text] [Related]
20. A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins.
Zavala-Ruiz Z; Strug I; Anderson MW; Gorski J; Stern LJ
Chem Biol; 2004 Oct; 11(10):1395-402. PubMed ID: 15489166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
